Silk Road Fund, a state-owned investment fund of the Chinese government, and the Indonesia Investment Authority, Indonesia's sovereign wealth fund, agreed to acquire a 40% stake in KF Group for $120m. This investment will be used to fund Kimia Farma Apotek’s strategic business expansion, working capital needs, and initiatives to further improve operational efficiency.